Review
doi: 10.1007/s00210-006-0042-9.
Epub 2006 Mar 11.
Drug transporters in pharmacokinetics
Affiliations
- PMID: 16532306
- DOI: 10.1007/s00210-006-0042-9
Item in Clipboard
Review
Drug transporters in pharmacokinetics
Naunyn Schmiedebergs Arch Pharmacol.
2006 Mar.
Abstract
This review deals with the drug transporters allowing drugs to enter and leave cells by carrier-mediated pathways. Emphasis is put on liver transporters but systems in gut, kidney, and blood-brain barrier are mentioned as well. Drug-drug interactions on carriers may provoke significant modification in pharmacokinetics as do carrier gene polymorphisms yielding functional carrier protein mutations. An integrated phase concept should reflect the interplay between drug metabolism and drug transport.
Similar articles
-
In vitro-in vivo extrapolation of transporter-mediated clearance in the liver and kidney.Drug Metab Pharmacokinet. 2009;24(1):37-52. doi: 10.2133/dmpk.24.37. Drug Metab Pharmacokinet. 2009. PMID: 19252335 Review.
-
Phase 0 and phase III transport in various organs: combined concept of phases in xenobiotic transport and metabolism.Drug Metab Rev. 2014 Aug;46(3):261-82. doi: 10.3109/03602532.2014.882353. Epub 2014 Jan 31. Drug Metab Rev. 2014. PMID: 24483608 Review.
-
EUFEPS conference on drug transporters at Copenhagen: integrative approaches in ADME research.Eur J Pharm Sci. 2005 Sep;26(1):130-43. doi: 10.1016/j.ejps.2005.07.001. Eur J Pharm Sci. 2005. PMID: 16161216 No abstract available.
-
Protein-protein interactions of drug uptake transporters that are important for liver and kidney.Biochem Pharmacol. 2019 Oct;168:384-391. doi: 10.1016/j.bcp.2019.07.026. Epub 2019 Aug 2. Biochem Pharmacol. 2019. PMID: 31381872 Free PMC article. Review.
-
The concept of fraction of drug transported (ft ) with special emphasis on BBB efflux of CNS and antiretroviral drugs.Clin Pharmacol Ther. 2015 Apr;97(4):320-3. doi: 10.1002/cpt.72. Epub 2015 Feb 13. Clin Pharmacol Ther. 2015. PMID: 25669655
Cited by
-
Characterization of substrates and inhibitors for the in vitro assessment of Bcrp mediated drug-drug interactions.Pharm Res. 2008 Oct;25(10):2320-6. doi: 10.1007/s11095-008-9632-1. Epub 2008 Jun 4. Pharm Res. 2008. PMID: 18523872
-
Cymbopogon citratus and Citral Overcome Doxorubicin Resistance in Cancer Cells via Modulating the Drug's Metabolism, Toxicity, and Multidrug Transporters.Molecules. 2023 Apr 12;28(8):3415. doi: 10.3390/molecules28083415. Molecules. 2023. PMID: 37110649 Free PMC article.
-
A Literature Review of Changes in Phase II Drug-Metabolizing Enzyme and Drug Transporter Expression during Pregnancy.Pharmaceutics. 2023 Nov 15;15(11):2624. doi: 10.3390/pharmaceutics15112624. Pharmaceutics. 2023. PMID: 38004602 Free PMC article. Review.
-
Development of precision medicine approaches based on inter-individual variability of BCRP/ABCG2.Acta Pharm Sin B. 2019 Jul;9(4):659-674. doi: 10.1016/j.apsb.2019.01.007. Epub 2019 Jan 15. Acta Pharm Sin B. 2019. PMID: 31384528 Free PMC article. Review.
-
An Updated Overview of the Role of CYP450 during Xenobiotic Metabolization in Regulating the Acute Myeloid Leukemia Microenvironment.Int J Mol Sci. 2023 Mar 23;24(7):6031. doi: 10.3390/ijms24076031. Int J Mol Sci. 2023. PMID: 37047003 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
